Financials
- Market Capitalization 25.1 B
- Employee 100
- Founded 1996
- CEO N/A
- Website www.royaltypharma.com
- Headquarter United Kingdom
- FIGI N/A
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
21.71
市销率
9.17
每股股息
0.88
股息收益率 %
2.28
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 386 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 288.06 USD | -3.58% | -8.97% | +1.82% | -9.10% | 38.46 B USD | ||
| 498 | MRNA Moderna, Inc. - Common Stock | 67.01 USD | -1.85% | -18.43% | +30.42% | +101.90% | 26.59 B USD | ||
| 518 | ROIV Roivant Sciences Ltd. - Common Shares | 34.51 USD | -4.06% | -2.73% | +14.80% | +88.48% | 24.82 B USD | ||
| 535 | INSM Insmed Incorporated - Common Stock | 109.14 USD | -5.60% | -3.60% | +10.53% | -32.65% | 23.66 B USD |